Accelerate to discover

Back to filter

Related topics

Preclinical lung imaging offers effective evaluation of drug candidates

Bruker Biospin

Mar 1, 2021

The incidence of respiratory disease is increasing throughout the world, and the demand for safe, effective drugs to...

Online courses on Stroke, Diabetes, VCID research

RWD

Feb 18, 2021

Are you interested in research of Stroke, Diabetes, or VCID Research? Do you want to share your knowledge with other...

Curiox Laminar Wash technology to become a gold standard for TotalSeq Protocol.

Curiox

Feb 15, 2021

Curiox Laminar Wash technology has been added as part of the official BioLegend TotalSeq Protocol. It makes processing...

Amnis CellStream's new software features - now better than ever

Luminex

Feb 12, 2021

It's finally here, and better than ever - Amnis CellStream's Acquisition and Analysis Software update increases ease of...

Mar 2, 2021

Anesthesia and Mechanical Ventilation in Small Animals

RWD

Feb 10, 2021

In this webinar, Prof. Pablo E. Otero, focusing on “Anesthesia and Mechanical Ventilation in Small Animals”. Help you...

The function of LSCI with off Line Model

RWD

Feb 10, 2021

In this video, we will show you how to change the pseudo-color off-line. At the same time, we will show you how to...

Magnetic resonance elastography: techniques and preclinical applications

Bruker Biospin

Feb 9, 2021

Magnetic resonance elastography (MRE) relies on the relationship between acoustic wave propagation and mechanical...

Mar 2, 2021

Towards silent and distortion-free fMRI with Zero Echo Time MRI

Bruker Biospin

Feb 9, 2021

By using fast imaging techniques capable of scanning large brain regions within short durations, continuous snapshots...

Show all topics (10)

Saphyr identifies all variants detected by the standard of care in cytogenetics

Jun 1, 2020

Dr. Rashmi Kanagal-Shamanna from the MD Anderson Cancer Center presented the study involving 100 samples of patients suffering from Myelodysplastic Syndrome (MDS), a precursor to AML. The clinical management of patients with MDS is largely determined by the number of structural aberrations detected, and therefore a single technology, like Saphyr, that is able to detect all CNVs and balanced rearrangements is desirable. A combined 39 aberrations that passed inclusion criteria were detected by karyotyping, and all of those variants were detected by Saphyr. Additionally, there was 100% concordance between Saphyr and calls made with CMA. Importantly, Bionano identified critical rearrangements important for prognostication of the disease and identified many novel aberrations that change the R-IPSS risk score, which would alter therapeutic management.

Discover more, whatch the webinar!

Application
Webinar

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

BioNano Genomics

A revolutionary NanoChannel technology for Genome mapping of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias.

Related products

Genome maps of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias

show detail

Saphyr provides rapid, high-throughput, long-range genome mapping with unmatched structural variation discovery capabilities

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey